Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Net Cash Flow (2019 - 2026)

Biodesix filings provide 8 years of Net Cash Flow readings, the most recent being $6.6 million for Q1 2026.

  • On a quarterly basis, Net Cash Flow rose 176.2% to $6.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.0 million, a 30.4% increase, with the full-year FY2025 number at -$7.3 million, down 18507.69% from a year prior.
  • Net Cash Flow hit $6.6 million in Q1 2026 for Biodesix, up from $2.4 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $30.7 million in Q2 2024 to a low of -$17.8 million in Q1 2023.
  • Median Net Cash Flow over the past 5 years was -$4.1 million (2025), compared with a mean of -$419882.4.
  • Biggest five-year swings in Net Cash Flow: soared 1092.06% in 2022 and later plummeted 544.8% in 2024.
  • Biodesix's Net Cash Flow stood at $27.9 million in 2022, then tumbled by 76.91% to $6.4 million in 2023, then crashed by 180.09% to -$5.2 million in 2024, then skyrocketed by 146.17% to $2.4 million in 2025, then skyrocketed by 176.33% to $6.6 million in 2026.
  • The last three reported values for Net Cash Flow were $6.6 million (Q1 2026), $2.4 million (Q4 2025), and -$4.1 million (Q3 2025) per Business Quant data.